Unicycive Therapeutics, Inc. (UNCY) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$31.32M | -9.6% |
| 2024 | -$28.57M | -56.3% |
| 2023 | -$18.28M | -16.8% |
| 2022 | -$15.65M | -171.4% |
| 2021 | -$5.77M | -295.3% |
| 2020 | -$1.46M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$31.32M | -9.6% |
| 2024 | -$28.57M | -56.3% |
| 2023 | -$18.28M | -16.8% |
| 2022 | -$15.65M | -171.4% |
| 2021 | -$5.77M | -295.3% |
| 2020 | -$1.46M | — |